These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 17410109

  • 1. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 2. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP.
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [Abstract] [Full Text] [Related]

  • 3. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 4. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [Abstract] [Full Text] [Related]

  • 5. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN, Elliott E, Nelson LA.
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [Abstract] [Full Text] [Related]

  • 6. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [Abstract] [Full Text] [Related]

  • 7. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 8. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R.
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [Abstract] [Full Text] [Related]

  • 9. Ramelteon: a novel treatment for the treatment of insomnia.
    Wurtman R.
    Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
    [Abstract] [Full Text] [Related]

  • 10. [A novel therapeutic drug: ramelteon].
    Miyamoto M.
    Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
    [Abstract] [Full Text] [Related]

  • 11. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V, Shankar PK.
    J Postgrad Med; 2008 Aug; 54(1):45-8. PubMed ID: 18296808
    [Abstract] [Full Text] [Related]

  • 12. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP.
    Travel Med Infect Dis; 2008 Aug; 6(1-2):17-28. PubMed ID: 18342269
    [Abstract] [Full Text] [Related]

  • 13. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 14. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.
    Karim A, Tolbert D, Cao C.
    J Clin Pharmacol; 2006 Feb; 46(2):140-8. PubMed ID: 16432265
    [Abstract] [Full Text] [Related]

  • 15. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.
    Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.
    Richardson G, Wang-Weigand S.
    Hum Psychopharmacol; 2009 Mar; 24(2):103-11. PubMed ID: 19090503
    [Abstract] [Full Text] [Related]

  • 17. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 18. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S, Watissée M, Roth T.
    Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
    [Abstract] [Full Text] [Related]

  • 19. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Oct; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 20. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Oct; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.